India Share Brokers | Equity Trading India | Derivative Trading in India | Share Brokers in India

Markets Navigation

Company Info.

Solara Active Pharma Sciences Ltd.

Income Statement - Consolidated

Market Cap.(`)	1846.79 Cr.	P/BV	1.23	Book Value (`)	416.48
52 Week High/Low ( ` )	606/286	FV/ML	10/1	P/E(X)	0.00
Book Closure	15/09/2023	EPS (`)	0.00	Div Yield (%)	0.00

(` in Crs.)

You can view the Consolidated Income Statement for the last 5 years.

Particulars	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19
Months	12	12	12	12	14
Source Of Info (AR = Annual Report, PR = Press Release)	AR	AR	AR	AR	AR
FaceValue	10.00	10.00	10.00	10.00	10.00


INCOME
Revenue From Operations [Net]	1379.19	1230.55	1575.73	1267.64	1322.08
Other Operating Revenues	64.62	37.79	41.15	54.11	64.59
Total Operating Revenues	1443.81	1268.34	1616.88	1321.75	1386.68

Other Income	22.55	20.02	28.77	27.52	12.38
Total Revenue	1466.36	1288.36	1645.65	1349.27	1399.06

EXPENSES
Cost Of Materials Consumed	773.90	858.86	683.77	623.36	729.54
Purchase Of Stock-In Trade	7.88	53.78	42.80	29.67	9.08
Changes In Inventories Of FG,WIP And Stock-In Trade	7.05	-258.75	-2.15	-54.16	-33.79
Employee Benefit Expenses	228.63	236.34	229.37	204.13	185.81
Finance Costs	90.06	75.28	84.48	77.89	82.42
Depreciation And Amortisation Expenses	111.19	112.32	108.66	94.16	83.09
Other Expenses	292.47	298.14	277.22	259.31	275.23
Total Expenses	1511.18	1375.97	1424.15	1234.36	1331.37

Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	-44.82	-87.61	221.50	114.91	67.69

Exceptional Items	0.00	-3.49	0.00	0.00	0.00
Profit/Loss Before Tax	-44.82	-91.10	221.50	114.91	67.69

Tax Expenses-Continued Operations
Current Tax	-0.09	0.17	38.80	21.22	15.97
Deferred Tax	-22.48	-32.98	-38.65	-20.69	-13.95
Tax For Earlier Years	0.00	0.00	0.00	-0.14	-1.43
Total Tax Expenses	-22.57	-32.81	0.15	0.39	0.59
Profit/Loss After Tax And Before ExtraOrdinary Items	-22.25	-58.29	221.35	114.52	67.10

Profit/Loss From Continuing Operations	-22.25	-58.29	221.35	114.52	67.10

Profit/Loss From Discontinuing Operations	0.00	0.00	0.00	0.00	-9.92
Total Tax Expenses Discontinuing Operations	0.00	0.00	0.00	0.00	-2.24
Net Profit/Loss From Discontinuing Operations	0.00	0.00	0.00	0.00	-7.68
Profit/Loss For The Period	-22.25	-58.29	221.35	114.52	59.43

Minority Interest	0.07	0.14	0.05	0.09	0.10
Consolidated Profit/Loss After MI And Associates	-22.18	-58.15	221.40	114.61	59.53

OTHER INFORMATION

EARNINGS PER SHARE
Basic EPS (Rs.)	-6.16	-16.18	69.00	44.29	21.77
Diluted EPS (Rs.)	-6.16	-16.18	64.53	42.82	21.73

DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend	0.00	10.78	19.72	15.63	0.00

Solara Active Pharma Sciences Ltd.

Balance Sheet - Consolidated

Market Cap.(`)	1846.79 Cr.	P/BV	1.23	Book Value (`)	416.48
52 Week High/Low ( ` )	606/286	FV/ML	10/1	P/E(X)	0.00
Book Closure	15/09/2023	EPS (`)	0.00	Div Yield (%)	0.00

(` in Crs.)

You can view the Consolidated Balance Sheet for the last 5 years.

Particulars	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19
Months	12	12	12	12	14
Source Of Info (AR = Annual Report, PR = Press Release)	AR	AR	AR	AR	AR
FaceValue	10.00	10.00	10.00	10.00	10.00
No. of Equity Shares (in Lacs)	359.96	359.96	359.30	268.55	257.74

EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	36.00	36.00	35.92	26.85	25.77
Total Share Capital	36.00	36.00	35.92	26.85	25.77

Reserves and Surplus	1463.16	1488.87	1552.60	963.09	826.09
Total Reserves and Surplus	1463.16	1488.87	1552.60	963.09	826.09
Employees Stock Options	1.05	0.00	0.00	0.00	0.00
Total Shareholders Funds	1500.21	1524.87	1588.52	989.94	851.87
Equity Share Application Money	0.00	0.00	0.00	96.00	104.00
Minority Interest	2.24	2.31	4.24	4.29	4.38

NON-CURRENT LIABILITIES
Long Term Borrowings	235.10	283.04	154.83	232.71	224.97
Deferred Tax Liabilities [Net]	0.00	0.00	0.00	11.83	32.83
Other Long Term Liabilities	49.93	61.83	65.88	78.31	77.61
Long Term Provisions	10.67	9.49	11.36	10.53	8.89
Total Non-Current Liabilities	295.70	354.36	232.07	333.38	344.30

CURRENT LIABILITIES
Short Term Borrowings	766.05	741.53	360.88	353.79	214.46
Trade Payables	305.86	283.56	309.30	216.12	244.39
Other Current Liabilities	27.14	42.46	116.74	158.12	195.09
Short Term Provisions	2.08	3.44	1.83	1.86	1.56
Total Current Liabilities	1101.13	1070.99	788.75	729.89	655.50

Total Capital And Liabilities	2899.28	2952.53	2613.58	2153.50	1960.04

ASSETS
NON-CURRENT ASSETS
Tangible Assets	944.52	923.38	936.51	939.57	749.82
Intangible Assets	54.35	67.94	79.98	92.28	102.87
Capital Work-In-Progress	238.47	238.65	87.98	40.47	40.37
Fixed Assets	1237.34	1229.97	1104.47	1072.32	893.07
Goodwill On Consolidation	365.09	365.09	365.09	365.09	358.63
Non-Current Investments	1.70	0.42	0.42	0.32	0.41
Deferred Tax Assets [Net]	78.56	55.14	25.61	0.07	0.07
Long Term Loans And Advances	0.00	0.27	0.15	0.02	0.02
Other Non-Current Assets	29.05	62.36	60.21	43.69	53.29
Total Non-Current Assets	1711.74	1713.25	1555.95	1481.51	1305.49


CURRENT ASSETS
Inventories	558.09	575.55	294.97	279.73	220.40
Trade Receivables	536.99	489.67	483.87	226.53	288.80
Cash And Cash Equivalents	8.89	47.25	198.54	56.78	76.47
Short Term Loans And Advances	32.62	51.58	1.65	52.34	2.34
OtherCurrentAssets	50.95	75.23	78.60	56.61	66.55
Total Current Assets	1187.54	1239.28	1057.63	671.99	654.55

Total Assets	2899.28	2952.53	2613.58	2153.50	1960.04

OTHER INFORMATION

CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	38.00	66.88	104.50	73.51	96.75

BONUS DETAILS
Bonus Equity Share Capital	9.07	9.07	9.07	0.00	0.00

NON-CURRENT INVESTMENTS
Non-Current Investments Unquoted Book Value	1.70	0.42	0.42	0.32	0.41

Attention Investors : “Prevent unauthorized transactions in your account ? Update your Mobile Numbers/Email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your Mobile/Email at the end of the day. Issued in the interest of Investors” ***** No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorize your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account. | | ***** KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (Broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary. | "Revised guidelines on margin collection ==> 1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. | 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. | 3. Pay 20% upfront margin of the transaction value to trade in cash market segment. | 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. | 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. .......... Issued in the interest of Investors" | ***** MEMBERS : SEBI Regn. No: NSE, BSE: INZ000176636 ; MCX : INZ000057535; SEBI Research Analyst Regn No: INH200000337; AMFI Regn No. 77624; Depository Participant : CDSL : IN-DP-CDSL-379-2006 DP ID : 12047600 | For any Grievance mail to : grievance@sharewealthindia.com | For any DP Grievance mail to : dpgrievance@sharewealthindia.com. | Grievance with SEBI : https://scores.gov.in/scores/Welcome.html

Share Wealth

Solara Active Pharma Sciences Ltd.

Income Statement - Consolidated

Solara Active Pharma Sciences Ltd.

Balance Sheet - Consolidated